| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPD1 DNAH10 MYO9B ACSM1 KIF4A CHD2 MSH4 DDX55 DICER1 DDX27 DNAH14 CHTF8 LONP1 ATP2C1 ATP11B ATP2C2 SMARCA1 KIF4B ATP13A3 ABCD2 | 4.10e-08 | 614 | 151 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSPD1 RERG DNAH10 MYO9B SEPTIN9 CHD2 DDX55 DDX27 LONP1 ATP2C1 ATP11B ATP2C2 ATP13A3 GNAZ SEPTIN7 DNM1 ABCD2 MX1 | 2.35e-05 | 775 | 151 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 4.82e-05 | 27 | 151 | 4 | GO:0033038 | |
| GeneOntologyMolecularFunction | P-type manganese transporter activity | 5.68e-05 | 2 | 151 | 2 | GO:0140613 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HSPD1 RERG DNAH10 MYO9B SEPTIN9 CHD2 DDX55 DDX27 LONP1 ATP2C1 ATP11B ATP2C2 ATP13A3 GNAZ SEPTIN7 DNM1 ABCD2 MX1 | 6.59e-05 | 839 | 151 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HSPD1 RERG DNAH10 MYO9B SEPTIN9 CHD2 DDX55 DDX27 LONP1 ATP2C1 ATP11B ATP2C2 ATP13A3 GNAZ SEPTIN7 DNM1 ABCD2 MX1 | 6.69e-05 | 840 | 151 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HSPD1 RERG DNAH10 MYO9B SEPTIN9 CHD2 DDX55 DDX27 LONP1 ATP2C1 ATP11B ATP2C2 ATP13A3 GNAZ SEPTIN7 DNM1 ABCD2 MX1 | 6.69e-05 | 840 | 151 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | taste receptor activity | 1.08e-04 | 33 | 151 | 4 | GO:0008527 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSPD1 DNAH10 MYO9B CHD2 DDX55 DDX27 LONP1 ATP2C1 ATP11B ATP2C2 ATP13A3 ABCD2 | 1.37e-04 | 441 | 151 | 12 | GO:0016887 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.65e-04 | 161 | 150 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | septin cytoskeleton | 1.89e-04 | 16 | 150 | 3 | GO:0032156 | |
| Domain | P-loop_NTPase | RERG DLG5 CMPK1 DNAH10 MYO9B SEPTIN9 APAF1 KIF4A CHD2 MSH4 DDX55 DICER1 DDX27 DNAH14 CASK NLRP6 LONP1 SMARCA1 KIF4B GNAZ SEPTIN7 DNM1 ABCD2 MX1 MPP7 | 1.45e-08 | 848 | 149 | 25 | IPR027417 |
| Domain | - | RERG DLG5 CMPK1 DNAH10 SEPTIN9 APAF1 CHD2 MSH4 DDX55 DICER1 DDX27 DNAH14 CASK LONP1 SMARCA1 GNAZ SEPTIN7 DNM1 ABCD2 MX1 MPP7 | 5.04e-07 | 746 | 149 | 21 | 3.40.50.300 |
| Domain | L27 | 2.63e-06 | 13 | 149 | 4 | SM00569 | |
| Domain | L27 | 2.63e-06 | 13 | 149 | 4 | PS51022 | |
| Domain | L27_dom | 2.63e-06 | 13 | 149 | 4 | IPR004172 | |
| Domain | PDZ | 1.76e-05 | 141 | 149 | 8 | PF00595 | |
| Domain | PDZ | 2.50e-05 | 148 | 149 | 8 | SM00228 | |
| Domain | - | 2.75e-05 | 150 | 149 | 8 | 2.30.42.10 | |
| Domain | PDZ | 2.88e-05 | 151 | 149 | 8 | PS50106 | |
| Domain | PDZ | 3.02e-05 | 152 | 149 | 8 | IPR001478 | |
| Domain | L27_C | 5.73e-05 | 10 | 149 | 3 | IPR014775 | |
| Domain | L27 | 5.73e-05 | 10 | 149 | 3 | PF02828 | |
| Domain | ARM-like | CKAP5 USP9Y TRRAP ARMCX1 ELMO1 EFR3A RIF1 WDFY3 TARBP1 PPP6R3 | 6.32e-05 | 270 | 149 | 10 | IPR011989 |
| Domain | P-type_ATPase_IIA_PMR1 | 6.32e-05 | 2 | 149 | 2 | IPR006413 | |
| Domain | ATPase_P-typ_P_site | 1.88e-04 | 36 | 149 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 1.88e-04 | 36 | 149 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.88e-04 | 36 | 149 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.09e-04 | 37 | 149 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.09e-04 | 37 | 149 | 4 | PF00122 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.12e-04 | 17 | 149 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 3.12e-04 | 17 | 149 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 3.72e-04 | 18 | 149 | 3 | PF00690 | |
| Domain | ARM-type_fold | CKAP5 USP9Y TRRAP ARMCX1 ELMO1 EFR3A RIF1 WDFY3 TARBP1 PPP6R3 | 4.00e-04 | 339 | 149 | 10 | IPR016024 |
| Domain | HAD-like_dom | 4.24e-04 | 79 | 149 | 5 | IPR023214 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.39e-04 | 19 | 149 | 3 | IPR004014 | |
| Domain | RDM_domain_RFPL | 6.22e-04 | 5 | 149 | 2 | IPR022723 | |
| Domain | RDM | 6.22e-04 | 5 | 149 | 2 | PF11002 | |
| Domain | GUANYLATE_KINASE_2 | 7.84e-04 | 23 | 149 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 7.84e-04 | 23 | 149 | 3 | PS00856 | |
| Domain | Dynamin_central | 9.29e-04 | 6 | 149 | 2 | IPR000375 | |
| Domain | GED | 9.29e-04 | 6 | 149 | 2 | SM00302 | |
| Domain | IL-1_rcpt_I/II-typ | 9.29e-04 | 6 | 149 | 2 | IPR004074 | |
| Domain | Dynamin_M | 9.29e-04 | 6 | 149 | 2 | PF01031 | |
| Domain | GED_dom | 9.29e-04 | 6 | 149 | 2 | IPR020850 | |
| Domain | ELMO_CED12 | 9.29e-04 | 6 | 149 | 2 | PF04727 | |
| Domain | LON_substr_bdg | 9.29e-04 | 6 | 149 | 2 | PF02190 | |
| Domain | LON | 9.29e-04 | 6 | 149 | 2 | SM00464 | |
| Domain | GED | 9.29e-04 | 6 | 149 | 2 | PS51388 | |
| Domain | ELMO | 9.29e-04 | 6 | 149 | 2 | PS51335 | |
| Domain | Dynamin_GTPase_CS | 9.29e-04 | 6 | 149 | 2 | IPR019762 | |
| Domain | GED | 9.29e-04 | 6 | 149 | 2 | PF02212 | |
| Domain | LON_N | 9.29e-04 | 6 | 149 | 2 | PS51787 | |
| Domain | GED | 9.29e-04 | 6 | 149 | 2 | IPR003130 | |
| Domain | LON_substr-bd_dom | 9.29e-04 | 6 | 149 | 2 | IPR003111 | |
| Domain | ELMO_dom | 9.29e-04 | 6 | 149 | 2 | IPR006816 | |
| Domain | Guanylate_kin | 1.13e-03 | 26 | 149 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 1.13e-03 | 26 | 149 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 1.13e-03 | 26 | 149 | 3 | IPR008144 | |
| Domain | GuKc | 1.13e-03 | 26 | 149 | 3 | SM00072 | |
| Domain | G_DYNAMIN_1 | 1.29e-03 | 7 | 149 | 2 | PS00410 | |
| Domain | DYNc | 1.29e-03 | 7 | 149 | 2 | SM00053 | |
| Domain | Helicase_C | 1.67e-03 | 107 | 149 | 5 | PF00271 | |
| Domain | HELICc | 1.67e-03 | 107 | 149 | 5 | SM00490 | |
| Domain | Helicase_C | 1.74e-03 | 108 | 149 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 1.81e-03 | 109 | 149 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.81e-03 | 109 | 149 | 5 | PS51192 | |
| Domain | DEXDc | 1.81e-03 | 109 | 149 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.89e-03 | 110 | 149 | 5 | IPR014001 | |
| Domain | - | 2.06e-03 | 222 | 149 | 7 | 1.25.10.10 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 2.25e-03 | 69 | 149 | 4 | IPR020636 | |
| Domain | ATPase_P-typ_cyto_domN | 2.70e-03 | 35 | 149 | 3 | IPR023299 | |
| Domain | A2M | 2.73e-03 | 10 | 149 | 2 | PF00207 | |
| Domain | A2M_N_2 | 2.73e-03 | 10 | 149 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.73e-03 | 10 | 149 | 2 | IPR011626 | |
| Domain | A2M_recep | 2.73e-03 | 10 | 149 | 2 | PF07677 | |
| Domain | A2M_comp | 2.73e-03 | 10 | 149 | 2 | PF07678 | |
| Domain | A2M_N | 2.73e-03 | 10 | 149 | 2 | PF01835 | |
| Domain | A2M_N | 2.73e-03 | 10 | 149 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.73e-03 | 10 | 149 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.73e-03 | 10 | 149 | 2 | PS00477 | |
| Domain | A2M_N_2 | 2.73e-03 | 10 | 149 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 2.73e-03 | 10 | 149 | 2 | IPR001599 | |
| Domain | CENP-B_N | 2.73e-03 | 10 | 149 | 2 | PF04218 | |
| Domain | IL-1_rcpt_fam | 3.32e-03 | 11 | 149 | 2 | IPR015621 | |
| Domain | HTH_Psq | 3.96e-03 | 12 | 149 | 2 | IPR007889 | |
| Domain | HTH_PSQ | 3.96e-03 | 12 | 149 | 2 | PS50960 | |
| Domain | CENPB | 3.96e-03 | 12 | 149 | 2 | SM00674 | |
| Domain | DDE_1 | 3.96e-03 | 12 | 149 | 2 | PF03184 | |
| Domain | DDE_SF_endonuclease_dom | 3.96e-03 | 12 | 149 | 2 | IPR004875 | |
| Domain | HTH_CENPB | 4.65e-03 | 13 | 149 | 2 | PS51253 | |
| Domain | G_SEPTIN_dom | 4.65e-03 | 13 | 149 | 2 | IPR030379 | |
| Domain | HTH_Tnp_Tc5 | 4.65e-03 | 13 | 149 | 2 | PF03221 | |
| Domain | Septin | 4.65e-03 | 13 | 149 | 2 | PF00735 | |
| Domain | HTH_CenpB_DNA-bd_dom | 4.65e-03 | 13 | 149 | 2 | IPR006600 | |
| Domain | G_SEPTIN | 4.65e-03 | 13 | 149 | 2 | PS51719 | |
| Domain | Rho_GTPase_activation_prot | 5.40e-03 | 88 | 149 | 4 | IPR008936 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.40e-03 | 14 | 149 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.40e-03 | 14 | 149 | 2 | IPR024743 | |
| Domain | G_DYNAMIN_dom | 5.40e-03 | 14 | 149 | 2 | IPR030381 | |
| Domain | MT | 5.40e-03 | 14 | 149 | 2 | PF12777 | |
| Domain | AAA_8 | 5.40e-03 | 14 | 149 | 2 | PF12780 | |
| Domain | Septin | 5.40e-03 | 14 | 149 | 2 | IPR016491 | |
| Domain | G_DYNAMIN_2 | 5.40e-03 | 14 | 149 | 2 | PS51718 | |
| Domain | DHC_fam | 6.20e-03 | 15 | 149 | 2 | IPR026983 | |
| Domain | Dynamin_GTPase | 6.20e-03 | 15 | 149 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 6.20e-03 | 15 | 149 | 2 | IPR022812 | |
| Domain | Dynein_heavy | 6.20e-03 | 15 | 149 | 2 | PF03028 | |
| Domain | Dynamin_N | 6.20e-03 | 15 | 149 | 2 | PF00350 | |
| Domain | Dynein_heavy_dom | 6.20e-03 | 15 | 149 | 2 | IPR004273 | |
| Domain | - | 6.56e-03 | 93 | 149 | 4 | 1.10.533.10 | |
| Pubmed | DLG5 POP4 LIN7C CKAP5 KIF4A RPS17 DIDO1 CHD2 SRGAP2 DDX55 TRRAP DICER1 DDX27 CASK EFR3A CSDE1 CHTF8 ACTR1A RIF1 ZNF800 TMF1 AFDN NOL7 PATJ MPP7 PPP6R3 | 2.41e-09 | 1497 | 154 | 26 | 31527615 | |
| Pubmed | ZHX3 CHD2 MSH4 CMYA5 MAPKAPK5 NME8 ELMO1 STX3 TIGD2 ATP11B ELMOD3 C5 EFCAB7 TARBP1 GPRC5B AKAP7 | 7.60e-08 | 686 | 154 | 16 | 29987050 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 TPR COPA MYO9B SEPTIN9 CKAP5 KIF4A RPS17 CHD2 TRRAP ARMCX1 DDX27 CSDE1 ACTR1A RIF1 LONP1 NAMPT SBDS SMARCA1 AFDN WDFY3 | 6.17e-07 | 1353 | 154 | 21 | 29467282 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | HSPD1 DLG5 CMPK1 MYO9B CKAP5 RPS17 DDX27 ACTR1A C2CD3 SERPINB8 C5 GNAZ SEPTIN7 QKI EFCAB7 | 1.01e-06 | 732 | 154 | 15 | 34732716 |
| Pubmed | TPR COPA CKAP5 KIF4A DIDO1 CHD2 TRRAP DICER1 DDX27 CSDE1 RIF1 LONP1 AFDN PPP6R3 | 1.39e-06 | 653 | 154 | 14 | 22586326 | |
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 15863617 | ||
| Pubmed | TPR DLG5 POP4 SEPTIN9 CKAP5 KIF4A TYMS CSDE1 ACTR1A SEPTIN7 PPP6R3 | 1.83e-06 | 399 | 154 | 11 | 37536630 | |
| Pubmed | HSPD1 TPR COPA SEPTIN9 COBLL1 KIF4A DIDO1 RIF1 CTDP1 TMF1 AFDN PPP6R3 | 2.75e-06 | 503 | 154 | 12 | 16964243 | |
| Pubmed | HSPD1 TPR ZHX3 HINT1 SEPTIN9 COBLL1 KIF4A TRRAP YEATS2 ACTR1A RIF1 SEPTIN7 | 2.92e-06 | 506 | 154 | 12 | 30890647 | |
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 1447303 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.69e-06 | 203 | 154 | 8 | 22083510 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | HSPD1 MCC RPS17 USP9Y DICER1 STRIP2 LONP1 WDFY3 PATJ AKAP7 PPP6R3 | 3.92e-06 | 432 | 154 | 11 | 23455922 |
| Pubmed | COPA LONRF1 CKAP5 SRGAP2 CMYA5 USP9Y DDX27 CASK CSDE1 USP2 AFDN ANKRD36 WDFY3 SEPTIN7 DNM1 QKI TARBP1 PICK1 LGI1 | 4.46e-06 | 1285 | 154 | 19 | 35914814 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | COPA IQGAP2 MYO9B CKAP5 KIF4A DIDO1 DDX55 TRRAP DDX27 CSDE1 RIF1 KIN NOL7 EFCAB7 | 7.80e-06 | 759 | 154 | 14 | 35915203 |
| Pubmed | Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry. | 8.10e-06 | 106 | 154 | 6 | 38891874 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DLG5 SEPTIN9 COBLL1 CKAP5 SRGAP2 EFR3A EHBP1L1 ELMOD3 AFDN SEPTIN7 PATJ MPP7 | 8.91e-06 | 565 | 154 | 12 | 25468996 |
| Pubmed | HSPD1 TPR KHDRBS2 CKAP5 UBL4A TRRAP CTDP1 METTL16 AKAP7 RPAP2 | 1.03e-05 | 390 | 154 | 10 | 17643375 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | LIN7C COPA UBL4A TRRAP DICER1 STRIP2 CASK USP2 LONP1 MRPL40 QKI TARBP1 MPP7 AKAP7 PPP6R3 RPAP2 | 1.08e-05 | 1005 | 154 | 16 | 19615732 |
| Pubmed | SEC16B DLG5 COPA IQGAP2 SEPTIN9 COBLL1 DIDO1 CHD2 DDX55 DICER1 DDX27 CSDE1 RIF1 NAMPT SMARCA1 NOL7 C5 QKI IL9 | 1.11e-05 | 1371 | 154 | 19 | 36244648 | |
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 1.37e-05 | 33 | 154 | 4 | 22357600 | |
| Pubmed | TPR LIN7C COPA UBL4A SRGAP2 ELMO1 TIAM2 CASK CSDE1 RIF1 LONP1 NOL7 SEPTIN7 PATJ PPP6R3 | 1.49e-05 | 916 | 154 | 15 | 32203420 | |
| Pubmed | HSPD1 TPR DLG5 COPA SEPTIN9 COBLL1 CKAP5 EFR3A CSDE1 AFDN SEPTIN7 PATJ MPP7 | 1.75e-05 | 708 | 154 | 13 | 39231216 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPD1 TPR ZHX3 HINT1 CAMK4 SEPTIN9 CKAP5 KIF4A DIDO1 SRGAP2 CSDE1 YEATS2 RIF1 NAMPT PPP6R3 | 1.87e-05 | 934 | 154 | 15 | 33916271 |
| Pubmed | 1.90e-05 | 419 | 154 | 10 | 15635413 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 1.95e-05 | 2 | 154 | 2 | 36482480 | |
| Pubmed | Secretory pathway Ca2+ -ATPases promote in vitro microcalcifications in breast cancer cells. | 1.95e-05 | 2 | 154 | 2 | 28618103 | |
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 1.95e-05 | 2 | 154 | 2 | 30081192 | |
| Pubmed | Septin9 is involved in septin filament formation and cellular stability. | 1.95e-05 | 2 | 154 | 2 | 21824004 | |
| Pubmed | Chromokinesin Kif4 promotes proper anaphase in mouse oocyte meiosis. | 1.95e-05 | 2 | 154 | 2 | 31067151 | |
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 1.95e-05 | 2 | 154 | 2 | 10559369 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21565503 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 7929562 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 16332677 | ||
| Pubmed | Whole genome expression microarray reveals novel roles for Kif4 in monocyte/macrophage cells. | 1.95e-05 | 2 | 154 | 2 | 31486502 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 10773663 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 31616463 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 28350061 | ||
| Pubmed | Kif4 interacts with EB1 and stabilizes microtubules downstream of Rho-mDia in migrating fibroblasts. | 1.95e-05 | 2 | 154 | 2 | 24658398 | |
| Pubmed | Structural basis for the ATP-induced isomerization of kinesin. | 1.95e-05 | 2 | 154 | 2 | 23500491 | |
| Pubmed | Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. | 1.95e-05 | 2 | 154 | 2 | 20305640 | |
| Pubmed | Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. | 1.95e-05 | 2 | 154 | 2 | 9658142 | |
| Pubmed | Mammalian SEPT9 isoforms direct microtubule-dependent arrangements of septin core heteromers. | 1.95e-05 | 2 | 154 | 2 | 22956766 | |
| Pubmed | TPR ACSM1 UBL4A DDX55 MAPKAPK5 TRRAP DICER1 RNF214 NAMPT ATP2C1 UBE3D SBDS CHEK2 ELMOD3 ATP13A3 METTL16 PADI3 PPP6R3 | 2.56e-05 | 1327 | 154 | 18 | 32694731 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSPD1 DLG5 COPA KHDRBS2 RPS17 DIDO1 CHD2 USP9Y DDX55 TRRAP CASK EHBP1L1 KIN MRPL40 DNM1 PZP | 2.66e-05 | 1082 | 154 | 16 | 38697112 |
| Pubmed | TPR IQGAP2 CKAP5 MCC KIF4A DIDO1 SRGAP2 CASK ACTR1A AFDN KIF4B WDFY3 SEPTIN7 DNM1 LGI1 | 2.66e-05 | 963 | 154 | 15 | 28671696 | |
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 2.92e-05 | 270 | 154 | 8 | 24366813 | |
| Pubmed | 3.30e-05 | 41 | 154 | 4 | 19343720 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO9B LONRF1 UBL4A GRID1 SRGAP2 MAPKAPK5 TRRAP TIAM2 ACTR1A EHBP1L1 C2CD3 CLCN7 CTDP1 WDFY3 GNAZ PICK1 | 3.42e-05 | 1105 | 154 | 16 | 35748872 |
| Pubmed | 3.50e-05 | 360 | 154 | 9 | 33111431 | ||
| Pubmed | TPR KIF4A DIDO1 TRRAP CSDE1 YEATS2 TET1 AFDN PATJ PPP6R3 RPAP2 | 3.62e-05 | 549 | 154 | 11 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR ZHX3 SEC16B COPA SEPTIN9 CKAP5 DIDO1 TRRAP YEATS2 RIF1 CTDP1 AFDN PPP6R3 | 4.38e-05 | 774 | 154 | 13 | 15302935 |
| Pubmed | TPR ZHX3 CMPK1 HINT1 COPA KIF4A DIDO1 CHD2 TRRAP CSDE1 RIF1 LONP1 NAMPT SBDS METTL16 | 4.79e-05 | 1014 | 154 | 15 | 32416067 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HSPD1 CMPK1 HINT1 IQGAP2 CAMK4 COBLL1 ACSM1 APAF1 GRID1 TIAM2 ACTR1A STX3 C5 PATJ GPRC5B | 4.90e-05 | 1016 | 154 | 15 | 19056867 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | IQGAP2 CASK EFR3A EHBP1L1 STX3 CLCN7 ELMOD3 ATP13A3 PATJ MPP7 GPRC5B | 4.99e-05 | 569 | 154 | 11 | 30639242 |
| Pubmed | 5.30e-05 | 216 | 154 | 7 | 31519766 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSPD1 TPR HINT1 LIN7C COPA IQGAP2 SEPTIN9 TCP11L1 CKAP5 RPS17 SRGAP2 ACTR1A AFDN SEPTIN7 PATJ TBCA | 5.44e-05 | 1149 | 154 | 16 | 35446349 |
| Pubmed | Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2). | 5.83e-05 | 3 | 154 | 2 | 8898719 | |
| Pubmed | The chloride antiporter CLCN7 is a modifier of lysosome dysfunction in FIG4 and VAC14 mutants. | 5.83e-05 | 3 | 154 | 2 | 37363915 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 16890532 | ||
| Pubmed | KIF4 mediates anterograde translocation and positioning of ribosomal constituents to axons. | 5.83e-05 | 3 | 154 | 2 | 19158085 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 17360756 | ||
| Pubmed | Identification of the human homologue of mouse KIF4, a kinesin superfamily motor protein. | 5.83e-05 | 3 | 154 | 2 | 10978527 | |
| Pubmed | Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes. | 5.83e-05 | 3 | 154 | 2 | 25327457 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 21767235 | ||
| Pubmed | Characterization of the TRBP domain required for dicer interaction and function in RNA interference. | 5.83e-05 | 3 | 154 | 2 | 19422693 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 11865057 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 22371183 | ||
| Pubmed | Structural basis for tandem L27 domain-mediated polymerization. | 5.83e-05 | 3 | 154 | 2 | 20702775 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 33689708 | ||
| Pubmed | KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. | 5.83e-05 | 3 | 154 | 2 | 16630823 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 35579738 | ||
| Pubmed | Store-independent activation of Orai1 by SPCA2 in mammary tumors. | 5.83e-05 | 3 | 154 | 2 | 20887894 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | HSPD1 TPR COPA SEPTIN9 CKAP5 KIF4A UBL4A ACTR1A RIF1 GSDME SEPTIN7 | 6.11e-05 | 582 | 154 | 11 | 20467437 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSPD1 TPR COPA DNAH10 CKAP5 RPS17 CMYA5 DDX55 DICER1 DDX27 ACTR1A RIF1 LONP1 NAMPT SMARCA1 AFDN NOL7 SEPTIN7 | 6.42e-05 | 1425 | 154 | 18 | 30948266 |
| Pubmed | 6.86e-05 | 225 | 154 | 7 | 31478661 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPR CMPK1 HINT1 COPA IQGAP2 SEPTIN9 APAF1 CASK SEPTIN7 PPP6R3 | 8.10e-05 | 498 | 154 | 10 | 36634849 |
| Pubmed | 9.40e-05 | 102 | 154 | 5 | 10231032 | ||
| Pubmed | CIN85 interacting proteins in B cells-specific role for SHIP-1. | 9.84e-05 | 54 | 154 | 4 | 21725061 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HSPD1 DLG5 SEPTIN9 CKAP5 DDX27 CSDE1 ACTR1A LONP1 C2CD3 SIMC1 AFDN SEPTIN7 PPP6R3 | 1.16e-04 | 853 | 154 | 13 | 28718761 |
| Pubmed | The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis. | 1.16e-04 | 4 | 154 | 2 | 12388755 | |
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 11230124 | ||
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 18684836 | ||
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 28125646 | ||
| Pubmed | Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. | 1.16e-04 | 4 | 154 | 2 | 10856295 | |
| Pubmed | SPCA2 regulates Orai1 trafficking and store independent Ca2+ entry in a model of lactation. | 1.16e-04 | 4 | 154 | 2 | 23840669 | |
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 23572511 | ||
| Pubmed | Biochemical and cell biological analyses of a mammalian septin complex, Sept7/9b/11. | 1.16e-04 | 4 | 154 | 2 | 15485874 | |
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 19568409 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | HSPD1 LIN7C CKAP5 MCC RPS17 DICER1 DDX27 CASK TYMS ATP2C1 AFDN QKI MPP7 PPP6R3 | 1.17e-04 | 974 | 154 | 14 | 28675297 |
| Pubmed | ZHX3 SEPTIN9 INPP5D CKAP5 KIF4A DIDO1 DDX55 TRRAP ELMO1 CSDE1 YEATS2 ACTR1A SBDS QKI TBCA | 1.22e-04 | 1103 | 154 | 15 | 34189442 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.24e-04 | 332 | 154 | 8 | 32786267 | |
| Pubmed | 1.32e-04 | 335 | 154 | 8 | 15741177 | ||
| Pubmed | HSPD1 COPA CKAP5 RPS17 CSDE1 ACTR1A RIF1 LONP1 NAMPT SEPTIN7 PPP6R3 | 1.37e-04 | 638 | 154 | 11 | 33239621 | |
| Pubmed | HSPD1 TPR DLG5 LIN7C COPA MYO9B SEPTIN9 KIF4A RPS17 DDX27 ACTR1A LONP1 SEPTIN7 PATJ PPP6R3 RPAP2 | 1.40e-04 | 1247 | 154 | 16 | 27684187 | |
| Pubmed | 1.41e-04 | 23 | 154 | 3 | 24945404 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.53e-04 | 256 | 154 | 7 | 33397691 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSPD1 TPR DLG5 COPA SEPTIN9 CKAP5 RPS17 DIDO1 DDX55 DDX27 CSDE1 ACTR1A KIN SMARCA1 SEPTIN7 PATJ | 1.53e-04 | 1257 | 154 | 16 | 36526897 |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 1.67e-04 | 442 | 154 | 9 | 15815621 | |
| Pubmed | 1.82e-04 | 25 | 154 | 3 | 21145499 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HSPD1 TPR COPA SEPTIN9 CKAP5 KIF4A RPS17 DIDO1 SRGAP2 DDX55 CSDE1 RIF1 LONP1 NAMPT TARBP1 PPP6R3 RPAP2 | 1.88e-04 | 1415 | 154 | 17 | 28515276 |
| GeneFamily | PDZ domain containing | 3.35e-06 | 152 | 107 | 8 | 1220 | |
| GeneFamily | Taste 2 receptors | 8.13e-05 | 39 | 107 | 4 | 1162 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 4.75e-04 | 26 | 107 | 3 | 904 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.22e-03 | 9 | 107 | 2 | 1234 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.22e-03 | 9 | 107 | 2 | 1223 | |
| GeneFamily | ATPases Ca2+ transporting | 1.22e-03 | 9 | 107 | 2 | 1209 | |
| GeneFamily | Helix-turn-helix CENPB type domain containing | 2.59e-03 | 13 | 107 | 2 | 533 | |
| GeneFamily | Septins | 2.59e-03 | 13 | 107 | 2 | 732 | |
| GeneFamily | Dyneins, axonemal | 4.45e-03 | 17 | 107 | 2 | 536 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 MYO9B SEPTIN9 CKAP5 SRGAP2 GCNT1 TRRAP DICER1 CASK EFR3A RIF1 C2CD3 NAMPT ATP2C1 ATP11B KIN SMARCA1 ATP13A3 WDFY3 QKI | 1.14e-07 | 856 | 151 | 20 | M4500 |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP | 2.54e-06 | 200 | 151 | 9 | M5817 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.02e-05 | 180 | 151 | 8 | M8239 | |
| Coexpression | GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN | 1.51e-05 | 137 | 151 | 7 | M406 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP | 2.11e-05 | 199 | 151 | 8 | M7325 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN | 2.18e-05 | 200 | 151 | 8 | M5816 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP | 4.43e-05 | 162 | 151 | 7 | M6673 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.26e-07 | 130 | 152 | 7 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-07 | 200 | 152 | 8 | e0cec0a844b7c1f8edee4c005af27766754e470a | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 8.98e-07 | 151 | 152 | 7 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.07e-06 | 155 | 152 | 7 | 189276a3b400b2202e6681e23732e6452bfe704e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-06 | 167 | 152 | 7 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.98e-06 | 170 | 152 | 7 | 4b1c84b35b7242a297ffdb9c23a6d982acf1bed5 | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 2.40e-06 | 175 | 152 | 7 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 2.69e-06 | 178 | 152 | 7 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 3.00e-06 | 181 | 152 | 7 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 3.00e-06 | 181 | 152 | 7 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 3.35e-06 | 184 | 152 | 7 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-06 | 186 | 152 | 7 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 4.00e-06 | 189 | 152 | 7 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.00e-06 | 189 | 152 | 7 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-06 | 191 | 152 | 7 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-06 | 191 | 152 | 7 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.28e-06 | 191 | 152 | 7 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.59e-06 | 193 | 152 | 7 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 4.59e-06 | 193 | 152 | 7 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 4.59e-06 | 193 | 152 | 7 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 4.59e-06 | 193 | 152 | 7 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.59e-06 | 193 | 152 | 7 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.59e-06 | 193 | 152 | 7 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.59e-06 | 193 | 152 | 7 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.59e-06 | 193 | 152 | 7 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.91e-06 | 195 | 152 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.42e-06 | 198 | 152 | 7 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.61e-06 | 199 | 152 | 7 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 | |
| ToppCell | RV-17._Lymphocyte|RV / Chamber and Cluster_Paper | 1.44e-05 | 153 | 152 | 6 | e1ea621184014415870e00d511386b8cc3e0833b | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8|bone_marrow / Manually curated celltypes from each tissue | 1.50e-05 | 154 | 152 | 6 | 93145a1bc5712ae664690b03a9e00ce1f92cfc7e | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-05 | 156 | 152 | 6 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.93e-05 | 161 | 152 | 6 | f5da03c426f3124ea302bd343b6bca81cafee858 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.00e-05 | 162 | 152 | 6 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.00e-05 | 162 | 152 | 6 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-05 | 162 | 152 | 6 | 4e3bf16799c6552366d4c7e42b1328a05dcad7e7 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.00e-05 | 162 | 152 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.07e-05 | 163 | 152 | 6 | b0aa4a620bd58011225b42ea6dda04e3101ba342 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-05 | 169 | 152 | 6 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 172 | 152 | 6 | c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 172 | 152 | 6 | 7c085c02b59e24e2a2cd393b5e692f9fb19257fe | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 2.89e-05 | 173 | 152 | 6 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.08e-05 | 175 | 152 | 6 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.08e-05 | 175 | 152 | 6 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.18e-05 | 176 | 152 | 6 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 177 | 152 | 6 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-05 | 179 | 152 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 3.84e-05 | 182 | 152 | 6 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 3.84e-05 | 182 | 152 | 6 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.84e-05 | 182 | 152 | 6 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.84e-05 | 182 | 152 | 6 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-05 | 183 | 152 | 6 | 91079a11685dd466bd27a0cf5afbf3734c08a05e | |
| ToppCell | RA-17._Lymphocyte|World / Chamber and Cluster_Paper | 3.95e-05 | 183 | 152 | 6 | 6397f684a50346fc42cccb5afbe10350f4b2d9b0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 184 | 152 | 6 | 6ce9aea2c1c9098f37bdf5135b5e2192ef03b50b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 184 | 152 | 6 | 895f7492d47c4782809bbb125c258127de04f888 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.60e-05 | 188 | 152 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.73e-05 | 189 | 152 | 6 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.73e-05 | 189 | 152 | 6 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 190 | 152 | 6 | ba61f04fd38efae01f721ba616252d1372ff1002 | |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 4.87e-05 | 190 | 152 | 6 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 4.87e-05 | 190 | 152 | 6 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 4.87e-05 | 190 | 152 | 6 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 190 | 152 | 6 | 5a37568000dfc33fcbb59b578c1963fb7cf872ec | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 5.02e-05 | 191 | 152 | 6 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 191 | 152 | 6 | d9506b88d806aadd4c2b9bf86fe994c47799e7f6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.02e-05 | 191 | 152 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 191 | 152 | 6 | b42c54308abe1241cc38ddce96b9d38d07983891 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.02e-05 | 191 | 152 | 6 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 5.02e-05 | 191 | 152 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.02e-05 | 191 | 152 | 6 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 191 | 152 | 6 | 9aabbc65430e2233b8f2d3fff9face7807b88b48 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 5.02e-05 | 191 | 152 | 6 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 5.17e-05 | 192 | 152 | 6 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 5.17e-05 | 192 | 152 | 6 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 5.17e-05 | 192 | 152 | 6 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | COVID-19_Severe-CD4+_Tcm|World / disease group, cell group and cell class | 5.17e-05 | 192 | 152 | 6 | 3352f13a6e706991dcf3ec173587bb6aba36a385 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.17e-05 | 192 | 152 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 5.17e-05 | 192 | 152 | 6 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Serpinb1a_(Serpinb1a)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.27e-05 | 60 | 152 | 4 | 48adafeec1810bce5f118fa63d4a8ee7ab9ca0f7 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Serpinb1a_(Serpinb1a)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.27e-05 | 60 | 152 | 4 | a83afb89dbfc2e1cdfce57320d89c980bd8fb820 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 5.32e-05 | 193 | 152 | 6 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.32e-05 | 193 | 152 | 6 | 498d3a83bce6deff69aea71b18a43688e0a8ed7d | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.32e-05 | 193 | 152 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type | 5.32e-05 | 193 | 152 | 6 | 780e23e2705fc5c1b70e37568b79731ced5038bd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 194 | 152 | 6 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.47e-05 | 194 | 152 | 6 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.47e-05 | 194 | 152 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 194 | 152 | 6 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 5.47e-05 | 194 | 152 | 6 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.63e-05 | 195 | 152 | 6 | 9b3fa1d42ec5aa2911f27a99cd8b57714c6bd604 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.63e-05 | 195 | 152 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.63e-05 | 195 | 152 | 6 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 5.79e-05 | 196 | 152 | 6 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 5.79e-05 | 196 | 152 | 6 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | severe_COVID-19-B_memory|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.79e-05 | 196 | 152 | 6 | c6e00cb59a88b9903cca233cefe05f80c5ea4153 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.96e-05 | 197 | 152 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.96e-05 | 197 | 152 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.96e-05 | 197 | 152 | 6 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.98e-05 | 121 | 152 | 5 | 4765e6ec00b0cf10d08cbd738c68a51d21bfb625 | |
| Disease | mean corpuscular hemoglobin concentration | ZHX3 IQGAP2 MYO9B COBLL1 KHDRBS2 NLRP6 TYMS RIF1 ZNF800 LONP1 EHBP1L1 ATP11B FAM222B CHEK2 KIF4B MRPL40 FBXL20 AKAP7 PPP6R3 | 2.41e-06 | 1105 | 146 | 19 | EFO_0004528 |
| Disease | Large cell carcinoma of lung | 1.86e-05 | 32 | 146 | 4 | C0345958 | |
| Disease | Schizophrenia | HINT1 MYO9B ACSM1 GRID1 ACOT6 CMYA5 TRRAP IL18R1 DICER1 SLC26A7 TET1 SEPTIN7 DNM1 QKI PICK1 | 3.42e-05 | 883 | 146 | 15 | C0036341 |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 2.41e-04 | 5 | 146 | 2 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 2.41e-04 | 5 | 146 | 2 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 2.41e-04 | 5 | 146 | 2 | DOID:0110197 (implicated_via_orthology) | |
| Disease | Lennox-Gastaut syndrome | 3.60e-04 | 6 | 146 | 2 | C0238111 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 3.60e-04 | 6 | 146 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | body surface area | SEC16B MYO9B DIDO1 GRID1 DICER1 TIAM2 UBE3D PATJ GPRC5B AKAP7 PPP6R3 | 3.72e-04 | 643 | 146 | 11 | EFO_0022196 |
| Disease | platelet component distribution width | RERG IQGAP2 MYO9B SEPTIN9 TCP11L1 COBLL1 ELMO1 CHEK2 ATP13A3 DNM1 QKI TBCA | 3.91e-04 | 755 | 146 | 12 | EFO_0007984 |
| Disease | sexual dimorphism measurement | SEC16B HINT1 LIN7C DNAH10 MYO9B COBLL1 TMPRSS12 DDX27 ACTR1A RNF214 EHBP1L1 PATJ GPRC5B AKAP7 PPP6R3 | 4.01e-04 | 1106 | 146 | 15 | EFO_0021796 |
| Disease | Rectal Neoplasms | 5.02e-04 | 7 | 146 | 2 | C0034885 | |
| Disease | Rectal Carcinoma | 5.02e-04 | 7 | 146 | 2 | C0007113 | |
| Disease | Neurodevelopmental Disorders | 1.19e-03 | 93 | 146 | 4 | C1535926 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.27e-03 | 43 | 146 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | complement C1q tumor necrosis factor-related protein 5 measurement | 1.30e-03 | 11 | 146 | 2 | EFO_0801494 | |
| Disease | Adenocarcinoma of large intestine | 1.34e-03 | 96 | 146 | 4 | C1319315 | |
| Disease | biliary liver cirrhosis | 1.35e-03 | 44 | 146 | 3 | EFO_0004267 | |
| Disease | hip circumference | 1.52e-03 | 338 | 146 | 7 | EFO_0005093 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.78e-03 | 447 | 146 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.83e-03 | 13 | 146 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | insulin measurement | 2.19e-03 | 267 | 146 | 6 | EFO_0004467 | |
| Disease | reticulocyte measurement | DNAH10 IQGAP2 MYO9B SEPTIN9 INPP5D COBLL1 LYG2 ZNF800 ATP11B CHEK2 AFDN FBXL20 QKI | 2.26e-03 | 1053 | 146 | 13 | EFO_0010700 |
| Disease | multiple myeloma | 2.36e-03 | 112 | 146 | 4 | EFO_0001378 | |
| Disease | BMI-adjusted leptin measurement | 2.45e-03 | 15 | 146 | 2 | EFO_0007793 | |
| Disease | triglycerides in medium VLDL measurement | 2.58e-03 | 55 | 146 | 3 | EFO_0022155 | |
| Disease | Drug habituation | 2.60e-03 | 115 | 146 | 4 | C0013170 | |
| Disease | Drug abuse | 2.60e-03 | 115 | 146 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.60e-03 | 115 | 146 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 2.60e-03 | 115 | 146 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 2.60e-03 | 115 | 146 | 4 | C0013222 | |
| Disease | Drug Dependence | 2.60e-03 | 115 | 146 | 4 | C1510472 | |
| Disease | Substance Dependence | 2.60e-03 | 115 | 146 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 2.60e-03 | 115 | 146 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.60e-03 | 115 | 146 | 4 | C0029231 | |
| Disease | Colorectal Neoplasms | 2.63e-03 | 277 | 146 | 6 | C0009404 | |
| Disease | Substance abuse problem | 2.68e-03 | 116 | 146 | 4 | C0740858 | |
| Disease | cholesterol to total lipids in large LDL percentage | 2.72e-03 | 56 | 146 | 3 | EFO_0022235 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.79e-03 | 16 | 146 | 2 | C0393706 | |
| Disease | obsolete_red blood cell distribution width | MYO9B UBL4A PGC ZNF800 LONP1 EHBP1L1 ATP11B FIG4 FAM222B SIMC1 CHEK2 AFDN FBXL20 PPP6R3 MPI | 2.84e-03 | 1347 | 146 | 15 | EFO_0005192 |
| Disease | colorectal cancer (is_implicated_in) | 3.12e-03 | 121 | 146 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 3.15e-03 | 17 | 146 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | bone density | 3.28e-03 | 388 | 146 | 7 | EFO_0003923 | |
| Disease | smoking behavior, body mass index | 3.31e-03 | 123 | 146 | 4 | EFO_0004318, EFO_0004340 | |
| Disease | triglycerides in small VLDL measurement | 3.46e-03 | 61 | 146 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 3.46e-03 | 61 | 146 | 3 | EFO_0022274 | |
| Disease | phospholipids in large VLDL measurement | 3.63e-03 | 62 | 146 | 3 | EFO_0022169 | |
| Disease | cystic fibrosis (is_marker_for) | 3.63e-03 | 62 | 146 | 3 | DOID:1485 (is_marker_for) | |
| Disease | phospholipids in very large VLDL measurement | 3.63e-03 | 62 | 146 | 3 | EFO_0022299 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 3.93e-03 | 19 | 146 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | carotid artery disease (is_marker_for) | 3.93e-03 | 19 | 146 | 2 | DOID:3407 (is_marker_for) | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 3.93e-03 | 19 | 146 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | triglyceride measurement, body mass index | 3.93e-03 | 19 | 146 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | cholesterol in large VLDL measurement | 4.14e-03 | 65 | 146 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 4.14e-03 | 65 | 146 | 3 | EFO_0022230 | |
| Disease | diet measurement, body mass index | 4.36e-03 | 20 | 146 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | total lipids in small VLDL | 4.51e-03 | 67 | 146 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 4.51e-03 | 67 | 146 | 3 | EFO_0022175 | |
| Disease | free cholesterol in large VLDL measurement | 4.70e-03 | 68 | 146 | 3 | EFO_0022265 | |
| Disease | ST2 protein measurement | 4.80e-03 | 21 | 146 | 2 | EFO_0010599 | |
| Disease | triglyceride measurement, body fat percentage | 4.80e-03 | 21 | 146 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | periodontitis (biomarker_via_orthology) | 4.80e-03 | 21 | 146 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | gastric ulcer | 4.80e-03 | 21 | 146 | 2 | EFO_0009454 | |
| Disease | Lymphoma, Diffuse | 4.80e-03 | 21 | 146 | 2 | C3714542 | |
| Disease | Low Grade Lymphoma (neoplasm) | 4.80e-03 | 21 | 146 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 4.80e-03 | 21 | 146 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 4.80e-03 | 21 | 146 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 4.80e-03 | 21 | 146 | 2 | C0079757 | |
| Disease | Lymphoma, Undifferentiated | 4.80e-03 | 21 | 146 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 4.80e-03 | 21 | 146 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 4.80e-03 | 21 | 146 | 2 | C0024304 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 4.90e-03 | 69 | 146 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEIAIIPSKKLRNKI | 36 | P08708 | |
| LRKEPEIITVTLKKQ | 1001 | P55196 | |
| LSILQKDVKVPTKVL | 386 | O14727 | |
| DIRKIVPELKSKVLA | 621 | Q9Y5B0 | |
| FVLKELEVLAKKSPR | 311 | Q96FG2 | |
| LKEKIQPEILELIKQ | 536 | Q92556 | |
| VTALIKDKILFKTRP | 96 | P0CG13 | |
| IVKSIVEKKPRTFII | 131 | Q9UBJ2 | |
| IPITNKEIIKGIKIL | 91 | Q9P0M2 | |
| IAVKVPSVFKLLIKE | 196 | Q9H7F0 | |
| LLKDKFIPKRIIIIA | 196 | O14862 | |
| IFDLKIQERVSKPKI | 121 | P06729 | |
| VKAVILKDSKVFPLL | 466 | O60443 | |
| IIPKLVDDLGKVKIT | 271 | Q3I5F7 | |
| KPIAVKLVKIKQEIL | 81 | O75534 | |
| SEIISKLYIPKRKII | 366 | A6QL64 | |
| QKIGIEIIKRTLKIP | 461 | P10809 | |
| DLVKKLLVVDPKARF | 461 | O96017 | |
| KFVTPKVIKLLEILR | 371 | Q9UPY3 | |
| IIPEKTVRVVINFKK | 141 | Q53SF7 | |
| LPQDVILKFRDKIEK | 591 | Q96GQ7 | |
| IIPDVADLKIKREKI | 501 | Q14156 | |
| VKKRAIVKKLPIVET | 326 | P98194 | |
| KKRVIVKKLPIVETL | 356 | O75185 | |
| NLEITIEKILSPKVK | 36 | Q9H4I0 | |
| IEKILSPKVKIALRT | 41 | Q9H4I0 | |
| VPEIKRKDTVIKTLL | 896 | P20742 | |
| IKLKRAVEEVKKLLV | 166 | Q96PU8 | |
| LQPEIIVKIITKKLG | 281 | O60870 | |
| FLKRLTLIKPELVIV | 301 | Q96LL4 | |
| ITLPDKERKKITREI | 21 | Q96PC3 | |
| EIISKLYIPKRKIIS | 401 | Q5JPF3 | |
| VVKLPAFKRKTLVLL | 731 | O14936 | |
| ERKIKIILIEFTPVT | 466 | Q13478 | |
| EKLQKAFEIAKRIPI | 196 | O75121 | |
| KVKLVVRYTPKVLEE | 166 | Q9NUP9 | |
| VRKLLKVKPEERLTI | 281 | Q8IW41 | |
| PVLKKLTELKAVLER | 306 | Q9UHH9 | |
| LVRKLIVLDPKKRLT | 276 | Q16566 | |
| TIVKKQVKKIREPCL | 411 | Q05193 | |
| VLSVQEKGVLLKRKL | 416 | Q17RB8 | |
| PILEILLRREEKLKK | 66 | Q8NHQ9 | |
| AKDLVSRLLVVDPKK | 586 | Q9C098 | |
| VKIPHVVRLKTLVIK | 216 | P51798 | |
| VQVRKIEIVRKKPIF | 151 | P01127 | |
| IEIVRKKPIFKKATV | 156 | P01127 | |
| LVPVEVIKPITLKAK | 711 | Q9HCM2 | |
| LLAIVKVPAKSILKD | 101 | Q8WU58 | |
| EIRELLKLLSKPNVK | 91 | Q5T2T1 | |
| KTLEPRVVFIKKSQL | 1496 | Q8TDM6 | |
| VPVRLRLKPKSVKVV | 131 | Q8N3D4 | |
| LSDLIKVVKVPQKTL | 151 | Q86W50 | |
| PRFIKIIEVKNKKLV | 136 | P36776 | |
| KRVVLTIKDKLDIIK | 6 | Q9Y4A0 | |
| KLRALVSIIKELEPK | 66 | A6NLU0 | |
| VSIIKELEPKLKSVL | 71 | A6NLU0 | |
| KIIRKEIPAKIIFED | 21 | P49773 | |
| IIDIPQLFKTERKKA | 566 | Q9ULW8 | |
| PLIFSRVKKSVEVLK | 86 | P15248 | |
| KKVVVEQLNLLVKRI | 206 | P34949 | |
| DIVPAKVLLVFRKLV | 136 | Q8N8X9 | |
| IEQKKRKLLPDTILE | 106 | Q9UMY1 | |
| ILLVRLPFIKEKEKK | 76 | Q9NZH0 | |
| IKVLPKLFESREKAV | 166 | Q14008 | |
| IPIAKIAERVKLSKT | 321 | P23508 | |
| KKKVEVEAIRILKPL | 226 | Q8N9C0 | |
| KKDLLAEKIRRIPLT | 271 | P19086 | |
| VKVPTKELLIKRSGI | 1321 | Q4AC94 | |
| LRKKIKPVTDEAQLV | 376 | A8K855 | |
| KVLEPFLLRRVKKDV | 691 | O14647 | |
| PIIILNLVKEREKRK | 371 | Q92562 | |
| IVGLSVETERKKLPK | 1061 | P53621 | |
| DLVPKTEIKRILSVK | 966 | P01031 | |
| KVLVEKTKTFLPVAL | 2626 | Q8N3K9 | |
| IGILDKTIKRKIAPV | 831 | Q9HC77 | |
| LAKLVRLKPEELVSK | 751 | Q9BTC0 | |
| PKELKRISLIFEKIS | 371 | Q8IZF7 | |
| SEVKKLAPKDVKIRI | 316 | P61163 | |
| IPDKVFVKLKKIVTL | 2416 | Q0VDD8 | |
| ILTERIKAIQKKFPT | 151 | Q86SG7 | |
| KIVPVEITISLLKRE | 61 | P30085 | |
| PRVIQLLFKEIDKKS | 116 | O95239 | |
| PRVIQLLFKEIDKKS | 116 | Q2VIQ3 | |
| VGILIKKPEEKISIF | 541 | Q9ULK0 | |
| KNIKLSERVLIPVKQ | 56 | Q5VWX1 | |
| FPIKTNLEIVRKLKL | 221 | Q02742 | |
| QTKLPIVRKVLDVIK | 296 | Q8IVF4 | |
| LKEKLKPLIKVIESE | 186 | Q9Y3A5 | |
| VKITKRFTKLLIAPE | 141 | P59044 | |
| APKFIIDLLAKIKTI | 76 | Q8NGF8 | |
| LKKRIKSVVLVILLG | 121 | P59542 | |
| LKRKAKSVVLVIVLG | 121 | P59543 | |
| LKKRIKSVVLVILLG | 121 | P0DSN6 | |
| LKRKAKSVVLVIVLG | 121 | P0DTE0 | |
| KLKDIKEIVPLFREI | 201 | Q9NUJ3 | |
| KLRALVSIIKELEPK | 66 | F8VTS6 | |
| VSIIKELEPKLKSVL | 71 | F8VTS6 | |
| KIRKLEKATQELIPI | 71 | Q9NQ50 | |
| VRKLQKERITILLPK | 121 | Q9BT43 | |
| KKTVNIPVLKVRKEI | 91 | Q32P41 | |
| LKPFLLRRIKTDVEK | 391 | P28370 | |
| VVFKSAPILKRALKV | 686 | Q9ULQ0 | |
| LIVLITKEEKKSPFL | 1556 | B5MCY1 | |
| ITEIEKKLPRLYKVL | 46 | Q5UIP0 | |
| IKTKKLIIDVIRNQP | 1301 | Q13576 | |
| EAVINKKLPKELLLR | 21 | Q96IG2 | |
| KRLSKVVNIVPVIAK | 431 | Q9UHD8 | |
| KIITKEDRLKVIPKL | 166 | O95707 | |
| KLVILVETEKEKILR | 356 | Q92835 | |
| SVIDRKDLIIKRIKP | 791 | Q8NDZ2 | |
| KVITKLKILSPLEII | 196 | O15457 | |
| VLKVLEILGKKFPVT | 321 | P43490 | |
| VVAVLRFIQLKPKVL | 81 | B9EJG8 | |
| LRIKKKKEETIPVII | 226 | P27930 | |
| RKKLIIIIVLVVVLL | 261 | Q13277 | |
| KSKVQVFLPRLKLEE | 261 | P50452 | |
| ILDEIKKPKNVTLIL | 101 | Q96A58 | |
| ELKKKPSVVVPLEVI | 626 | Q8NFU7 | |
| LPKTITGKIERKELR | 556 | Q08AH1 | |
| IIAKLIKTKDPIIRE | 251 | Q9P291 | |
| AKVIRLIKISPEKPI | 801 | Q9Y2G3 | |
| PVDKLEKILEKLLTR | 551 | Q8ND24 | |
| TRILKPKEKILFINL | 56 | Q8WWB5 | |
| KRVVLTIKDKLDIIK | 6 | Q4W5G0 | |
| LEEKVKEIPKLRTQL | 1031 | P82094 | |
| VDKNIDRFIPITKLK | 96 | Q5BJH7 | |
| KKQVLEELFKVTLPV | 2211 | Q8IZQ1 | |
| KPLVTVQKERKLELV | 516 | Q8IVF5 | |
| KPDAVISKKVLEIKR | 161 | Q8N427 | |
| LQLLEAAVVKVPLKK | 11 | P20142 | |
| IRKRIVLEKLSKVLP | 501 | Q8IXW5 | |
| IVKEVEAKAPILKRQ | 426 | P12270 | |
| IIKTAPSKVKLVFIR | 1306 | Q8NI35 | |
| LVKKIKDRLPLAVVG | 236 | Q16181 | |
| EVIIKDRKLLRVLPL | 116 | Q7Z6J8 | |
| IRKVLLVLPKTTLII | 601 | O75044 | |
| QRIIKKFKVEIILDP | 286 | A6NK02 | |
| FPKLRILRKVEKIDD | 276 | P04818 | |
| KIKIKAIIIHPNFIL | 151 | Q86WS5 | |
| DTVKRLLIKKLPRVL | 1781 | O00507 | |
| LEKELVNKEIIRSKP | 336 | Q8TEA7 | |
| PVLLVELIKLAEKLK | 666 | Q96JE7 | |
| KLNLVVKPLEKVLLE | 66 | P11441 | |
| KITASLEIRAIKKPI | 551 | Q2TB10 | |
| EPLQVRVKAVLKKRE | 106 | Q6PML9 | |
| FKPKIELVITKFLRI | 291 | Q5TAH2 | |
| IPEKKLILKQALIVV | 1261 | Q13395 | |
| TKIITKVVEPKIKVI | 671 | Q15063 | |
| FKRKIKVVLPVDLVL | 251 | Q8TE54 | |
| EKIRALEPLKAKLVT | 111 | Q2TAA8 | |
| IKKFSIQRFPKILVL | 486 | O75604 | |
| ILAERKVSPIKINLK | 716 | Q9H4I2 | |
| SIEKFGIRLLKTIKP | 216 | Q9NRD5 | |
| LISRKPEQIVDFLKK | 131 | Q5H9R7 | |
| VRQIKIKTGVVKRLV | 6 | O75347 | |
| EKSPDAKILRAVVKI | 2356 | Q9Y4A5 | |
| ILSLSEPVKINIKKE | 1296 | Q9ULM3 | |
| ILKIRKPNDIETFKI | 326 | O95970 | |
| IVTRCPLVLKLKKLV | 101 | P20591 | |
| LLKVKREILVEVLTK | 441 | Q13459 |